Coregulatory Proteins in Nuclear Hormone Receptor Action

Ali, 1993, Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region., EMBO J., 12, 1153, 10.1002/j.1460-2075.1993.tb05756.x Allan, 1992, Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation., J. Biol. Chem., 267, 19513, 10.1016/S0021-9258(18)41805-4 Allan, 1996, Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail., Mol. Endocrinol., 10, 1206, 10.1210/me.10.10.1206 Alland, 1997, Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression., Nature (London, 387, 49, 10.1038/387049a0 Almlöf, 1995, Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor., J. Biol. Chem., 270, 17535, 10.1074/jbc.270.29.17535 Anzick, 1997, AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer., Science, 277, 965, 10.1126/science.277.5328.965 Arnold, 1994, Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor., Mol. Endocrinol., 8, 1208, 10.1210/me.8.9.1208 Bagchi, 1988, Steroid hormone-dependent interaction of human progesterone receptor with its target enhancer element., Mol. Endocrinol., 2, 1221, 10.1210/mend-2-12-1221 Bai, 1996, Phosphorylation of Ser211 in the chicken progesterone receptor modulates its transcriptional activity., J. Biol. Chem., 271, 12801, 10.1074/jbc.271.22.12801 Bannister, 1996, The CBP co-activator is a histone acetyl-transferase., Nature (London, 384, 641, 10.1038/384641a0 Bartsch, 1996, Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure., Proc. Natl. Acad. Sci. U.S.A., 93, 10741, 10.1073/pnas.93.20.10741 Barzel, 1988, Estrogen in the prevention and treatment of postmenopausal osteoporosis., Am. J. Med., 85, 847, 10.1016/S0002-9343(88)80033-0 Beato, 1996, Interaction of steroid hormone receptors with the transcription initiation complex., Endocr. Rev., 17, 587, 10.1210/edrv-17-6-587 Beck, 1992, Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors., Mol. Endocrinol., 6, 607, 10.1210/me.6.4.607 Beck, 1996, Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor., J. Biol. Chem., 271, 1209, 10.1074/jbc.271.2.1209 Beebe, 1991, 3.5,3'-triiodothyronine receptor auxiliary protein (TRAP) enhances receptor binding by interactions within the thyroid hormone response element., Mol. Endocrinol., 5, 85, 10.1210/mend-5-1-85 Beekman, 1993, Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain., Mol. Endocrinol., 7, 1266, 10.1210/me.7.10.1266 Berger, 1992, Genetic isolation of ADA2: A potential transcriptional adaptor required for function of certain acidic Activation domains., Cell (Cambridge, Mass., 70, 251, 10.1016/0092-8674(92)90100-Q Berry, 1990, Role of the two activating domains of the oestrogen receptor in cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamaxifen., EMBO J., 9, 2811, 10.1002/j.1460-2075.1990.tb07469.x Bhat, 1993, Conformational changes of human β1 thyroid hormone receptor induced by binding of 3,3', 5-triiodo-1-thyronnine., Biochem. Biophys. Res. Commun., 195, 385, 10.1006/bbrc.1993.2055 Bhattacharya, 1996, Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α., Nature (London, 383, 344, 10.1038/383344a0 Blanco, 1995, Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription., Proc. Natl. Acad. Sci. U.S.A., 92, 1535, 10.1073/pnas.92.5.1535 Bocquel, 1989, The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor- and cell-specific., Nucleic Acids Res., 17, 2581, 10.1093/nar/17.7.2581 Boonyaratanakornkit, 1998, High mobility group chromatin proteins-1 and -2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells., Mol. Cell. Biol., 18, 10.1128/MCB.18.8.4471 Bourguet, 1995, Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α., Nature (London, 375, 377, 10.1038/375377a0 Brownell, 1996, Special HATs for special occasions: Linking histone acetylation to chromatin assembly and gene activation., Curr. Opin. Genet. Dev., 6, 176, 10.1016/S0959-437X(96)80048-7 Brownell, 1996, Tetrahymena histone acetyltransferase A: A homolog to yeast Genop linking histone acetylation to gene activation., Cell (Cambridge, Mass., 84, 843, 10.1016/S0092-8674(00)81063-6 Brzozowski, 1997, Molecular basis of agonism and antagonism in the oestrogen receptor., Nature (London, 389, 753, 10.1038/39645 Burns, 1997, Calreticulin inhibits glucocorticoid—but not cAMP-sensitive expression of tyrosine aminotransferase gene in cultured McA-RH7777 hepatocytes., Mol. Cell. Biochem., 171, 37, 10.1023/A:1006865108833 Burns, 1994, Modulation of gene expression by calreticulin binding to the glucocorticoid receptor., Nature (London, 376, 476, 10.1038/367476a0 Burnside, 1990, A nuclear factor that enhances binding of thyroid hormone receptors to thyroid hormone response elements., J. Biol. Chem., 265, 2500, 10.1016/S0021-9258(19)39828-X Burris, 1995, A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors., Proc. Natl. Acad. Sci. U.S.A., 92, 9525, 10.1073/pnas.92.21.9525 Bustin, 1996, High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function., Prog. Nucleic Acid Res. Mol. Biol., 54, 35, 10.1016/S0079-6603(08)60360-8 Cavailles, 1994, Interaction of proteins with transcriptionally active estrogen receptors., Proc. Natl. Acad. Sci. U.S.A., 91, 10009, 10.1073/pnas.91.21.10009 Cavailles, 1995, Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor., EMBO J., 14, 3741, 10.1002/j.1460-2075.1995.tb00044.x Cavanaugh, 1990, Glucocorticoid receptor binding to calf thymus DNA. 1. Identification and characterization of a macromolecular factor involved in receptor-steroid complex binding to DNA., J. Biol. Chem., 29, 989 Cavanaugh, 1994, Factor-assisted DNA binding as a possible general mechanism for steroid receptors. Functional heterogeneity among activated receptor-steroid complexes., J. Steroid Biochem. Mol. Biol., 48, 433, 10.1016/0960-0760(94)90191-0 Chakravarti, 1996, Role of CBP/p300 in nuclear receptor signalling., Nature (London, 383, 99, 10.1038/383099a0 Chen, 1997, Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300., Cell (Cambridge, Mass., 90, 569, 10.1016/S0092-8674(00)80516-4 Chen, 1995, A transcriptional co-repressor that interacts with nuclear hormone receptors., Nature (London, 377, 454, 10.1038/377454a0 Chrivia, 1993, Phosphorylated CREB binds specifically to the nuclear protein CBP., Nature (London, 365, 855, 10.1038/365855a0 Clemm, 1995, Definition of the critical cellular components which distinguish between hormone and anti-hormone activated progesterone receptor., J. Steroid Biochem. Mol. Biol., 53, 487, 10.1016/0960-0760(95)00095-H Dahlman-Wright, 1996, Structural studies of mutant glucocorticoid receptor transactivation domains establish a link between transactivation activity in vivo and α-helix-forming potential, in vitro. J. Biol. Chem., 35, 1323 Dahlman-Wright, 1995, Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor., Proc. Natl. Acad. Sci. U.S.A., 92, 1699, 10.1073/pnas.92.5.1699 Danielian, 1992, Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptor., EMBO J., 11, 1025, 10.1002/j.1460-2075.1992.tb05141.x Dedhar, 1994, Inhibition of nuclear hormone receptor activity by calreticulin., Nature (London, 367, 480, 10.1038/367480a0 Delabre, 1993, In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA., Proc. Natl. Acad. Sci. U.S.A., 90, 4421, 10.1073/pnas.90.10.4421 Desai, 1996, Inhibition of retinoic acid receptor function and retinoic acid-regulated gene expression in mouse melanoma cells by calreticulin., J. Biol. Chem., 271, 15153, 10.1074/jbc.271.25.15153 Devchand, 1996, The PPARα-leukotriene B4 pathway to inflammation control., Nature (London, 384, 39, 10.1038/384039a0 De Vos, 1994, Nuclear extracts enhance the interaction of fusion proteins containing the DNA-binding domain of the androgen and glucocorticoid receptor with androgen and glucocorticoid response elements., J. Steroid Biochem. Mol. Biol., 48, 317, 10.1016/0960-0760(94)90071-X Ding, 1998, Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities., Mol. Endocrinol., 12, 302, 10.1210/me.12.2.302 Direnzo, 1997, Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the itneractions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors., Mol. Cell. Biol., 17, 2166, 10.1128/MCB.17.4.2166 Edwards, 1989, Human progesterone receptor binding to mouse mammary tumor virus deoxyribonucleic acid: Dependence on hormone and nonreceptor nuclear factor(s)., Mol. Endocrinol., 3, 381, 10.1210/mend-3-2-381 Eisenmann, 1992, SPT3 interacts with TFIID to allow normal transcription in saccharomyces cerevisiae., Genes Dev., 6, 1319, 10.1101/gad.6.7.1319 Enmark, 1996, Orphan nuclear receptors—the first eight years., Mol. Endocrinol., 10, 1293, 10.1210/me.10.11.1293 Feavers, 1987, Interaction of two nonhistone proteins with the estradiol response element of the avian vitellogenin gene modulates the binding of estradiol-receptor complex., Proc. Natl. Acad. Sci. U.S.A., 84, 7453, 10.1073/pnas.84.21.7453 Felson, 1993, The effect of postmenopausal estrogen therapy on bone density in elderly women., N. Engl. J. Med., 329, 1141, 10.1056/NEJM199310143291601 Ferrari, 1992, SRY, like HMG1, recognizes sharp angles in DNA., EMBO J., 11, 4497, 10.1002/j.1460-2075.1992.tb05551.x Forman, 1995, Identification of a nuclear receptor that is activated by farnesol metabolites., Cell (Cambridge, Mass., 81, 687, 10.1016/0092-8674(95)90530-8 Forman, 1997, The orphan nuclear receptor LXRα is positively and negatively regulated by distinct products of mevalonate metabolism., Proc. Natl. Acad. Sci. U.S.A., 94, 10588, 10.1073/pnas.94.20.10588 Freedman, 1992, Anatomy of the steroid receptor zinc finger region., Endocr. Rev., 13, 129, 10.1210/edrv-13-2-129 Fitsch, 1992, DNA allosterically modulates the steroid binding domain of the estrogen receptor., J. Biol. Chem., 267, 1823, 10.1016/S0021-9258(18)46020-6 Gass, 1998, The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to DNA in vitro and in vivo but have distinct effects on receptor conformation, Endocrinology (Baltimore, 139, 1905, 10.1210/en.139.4.1905 Giese, 1992, The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures., Cell (Cambridge, Mass., 69, 185, 10.1016/0092-8674(92)90129-Z Gill, 1998, Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1., Mol. Endocrinol., 12, 57, 10.1210/me.12.1.57 Glass, 1994, Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers., Endocr. Rev., 15, 391 Glass, 1997, Nuclear receptor coactivators., Curr. Opin. Cell Biol., 9, 222, 10.1016/S0955-0674(97)80066-X Goodrich, 1994, TBP-TAF complexes: Selectivity factors for eukaryotic transcription., Curr. Opin. Cell Biol., 6, 403, 10.1016/0955-0674(94)90033-7 Grosschedi, 1994, HMG domain proteins: Architectural elements in the assembly of nucleoprotein structures., Trends Genet., 10, 94, 10.1016/0168-9525(94)90232-1 Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 c-terminal domain., Cell (Cambridge, Mass., 90, 595, 10.1016/S0092-8674(00)80521-8 Halachmi, 1994, Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription., Science, 264, 1455, 10.1126/science.8197458 Hanstein, 1996, P300 is a component of an estrogen receptor coactivator complex., Proc. Natl. Acad. Sci. U.S.A., 93, 11540, 10.1073/pnas.93.21.11540 Härd, 1990, Solution structure of the glucocorticoid receptor DNA-binding domain., Science, 249, 157, 10.1126/science.2115209 Heery, 1997, A signature motif in transcriptional co-activators mediates binding to nuclear receptors., Nature (London, 387, 733, 10.1038/42750 Heinzel, 1997, A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression., Nature (London, 387, 43, 10.1038/387043a0 Henttu, 1997, AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors., Mol. Cell. Biol., 17, 1832, 10.1128/MCB.17.4.1832 Heyman, 1992, 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor., Cell (Cambridge, Mass., 68, 397, 10.1016/0092-8674(92)90479-V Hong, 1996, GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors., Proc. Natl. Acad. Sci. U.S.A., 93, 4948, 10.1073/pnas.93.10.4948 Hong, 1997, GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors., Mol. Cell. Biol., 17, 2735, 10.1128/MCB.17.5.2735 Hörlein, 1995, Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor., Nature (London, 377, 397, 10.1038/377397a0 Horwitz, 1996, Nuclear receptor coactivators and corepressors., Mol. Endocrinol., 10, 1167, 10.1210/me.10.10.1167 Hu, 1993, Circumvention of tamoxifen resistance by the pure anti-estrogen ICI182, 780., Int. J. Cancer, 55, 873, 10.1002/ijc.2910550529 Huang, 1993, PAS is a dimerization domain common to Drosophila period and several transcription factors., Nature (London, 364, 259, 10.1038/364259a0 Hughes, 1989, Purification and characterization of a protein from HeLa cells that binds with high affinity to the estrogen response element, GGTCAGCGTGACC., J. Biol. Chem., 28, 9137 Huibregtse, 1995, A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase., Proc. Natl. Acad. Sci. U.S.A., 92, 2563, 10.1073/pnas.92.7.2563 Ikonen, 1997, Interaction between the Amino- and Carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators., J. Biol. Chem., 272, 29821, 10.1074/jbc.272.47.29821 Imhof, 1996, Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors., Mol. Cell. Biol., 16, 2594, 10.1128/MCB.16.6.2594 Ing, 1992, Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II)., J. Biol. Chem., 267, 17617, 10.1016/S0021-9258(19)37087-5 Jackson, 1997, The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT., Mol. Endocrinol., 11, 693, 10.1210/me.11.6.693 Jacq, 1994, Human TAFII30 is present in a district TFIID complex and is required for transcriptional activation by the estrogen receptor., Cell (Cambridge, Mass., 79, 107, 10.1016/0092-8674(94)90404-9 Janowski, 1996, An oxysterol signalling pathway mediated by the nuclear receptor LXRα., Nature (London, 383, 728, 10.1038/383728a0 Jayaraman, 1998, High mobility group protein-1 (HMG-1) is a unique activator of p53., Genes Devel., 12, 463, 10.1101/gad.12.4.462 Jenster, 1997, Steroid receptor induction of gene transcription: a two-step model., Proc. Natl. Acad. Sci. U.S.A., 94, 7879, 10.1073/pnas.94.15.7879 Jeyakumar, 1997, Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor., Mol. Endocrinol., 11, 755, 10.1210/me.11.6.755 Jordan, 1987, Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration of node-positive patients with breast cancer., Cancer Res., 47, 624 Joyeux, 1997, RIP 140 enhances nuclear receptor-dependent transcription in vivo in yeast., Mol. Endocrinol., 11, 193, 10.1210/me.11.2.193 Kamei, 1996, A CBP integrator complex mediates transcriptional activation and AP-1 inhibitor by nuclear receptors., Cell (Cambridge, Mass., 85, 403, 10.1016/S0092-8674(00)81118-6 Kedar, 1994, Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial., Lancet, 343, 1318, 10.1016/S0140-6736(94)92466-X Kee, 1996, Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator., J. Biol. Chem., 271, 2373, 10.1074/jbc.271.5.2373 King, 1993, Thyroid hormone receptor-induced bending of specific DNA sequences is modified by an accessory factor., J. Biol. Chem., 268, 495, 10.1016/S0021-9258(18)54178-8 Klein-Hitpass, 1991, Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells., Nucleic Acids Res., 19, 1227, 10.1093/nar/19.6.1227 Kliewer, 1992, Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling., Nature (London, 355, 446, 10.1038/355446a0 Kliewer, 1995, A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation., Cell (Cambridge, Mass., 83, 813, 10.1016/0092-8674(95)90194-9 Kuil, 1996, Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: Implications for the action of androgens and antiandrogens., Endocrinology (Baltimore, 137, 1870, 10.1210/en.137.5.1870 Kuil, 1995, Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization., J. Biol. Chem., 270, 27569, 10.1074/jbc.270.46.27569 Kumar, 1988, The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer., Cell (Cambridge, Mass., 55, 145, 10.1016/0092-8674(88)90017-7 Kupfer, 1993, Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors., J. Biol. Chem., 268, 17519, 10.1016/S0021-9258(19)85364-4 Kupfer, 1994, Androgen and glucocorticoid receptors interact with insulin degrading enzyme., J. Biol. Chem., 269, 20622, 10.1016/S0021-9258(17)32038-0 Kwok, 1994, Nuclear protein CBP is a coactivator for the transcription factor CREB., Nature (London, 370, 223, 10.1038/370223a0 Landel, 1994, The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins., Mol. Endocrinol., 8, 1407, 10.1210/me.8.10.1407 Landsman, 1993, A signature for the HMG-1 box DNA-binding proteins., BioEssays, 15, 539, 10.1002/bies.950150807 Le Douarin, 1995, The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors is fused to B-raf in the oncogenic protein T18., EMBO J., 14, 2020, 10.1002/j.1460-2075.1995.tb07194.x Le Douarin, 1996, A possible involvement of TIFα and TIF1β in the epigenetic control of transcription by nuclear receptors., EMBO J., 15, 6701, 10.1002/j.1460-2075.1996.tb01060.x Lee, 1995, Interaction of thyroid-hormone receptor with a conserved transcriptional mediator., Nature (London, 374, 91, 10.1038/374091a0 Lee, 1995, Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor., Mol. Endocrinol., 9, 243, 10.1210/me.9.2.243 Lee, 1993, Structure of the retinoid X receptor α DNA binding domain: A helix required for homodimeric DNA binding., Science, 260, 1117, 10.1126/science.8388124 Lees, 1989, Identification of two transactivation domain in the mouse oestrogen receptor., Nucleic Acids Res., 17, 5477, 10.1093/nar/17.14.5477 Lefstin, 1994, Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions., Genes Dev., 8, 2842, 10.1101/gad.8.23.2842 Leid, 1994, Ligand-induced alternation of the protease sensitivity of retinoid X receptor α., J. Biol. Chem., 269, 14175, 10.1016/S0021-9258(17)36771-6 Leid, 1992, Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently., Cell (Cambridge, Mass., 68, 377, 10.1016/0092-8674(92)90478-U Leidig, 1992, Thyroid hormone responsiveness in human growth hormone-related genes., J. Biol. Chem., 267, 913, 10.1016/S0021-9258(18)48371-8 Levin, 1992, 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα., Nature (London, 355, 359, 10.1038/355359a0 L'Horset, 1996, RIP-140 interacts with multiple nuclear receptors by means of two distinct sites., Mol. Cell. Biol., 16, 6029, 10.1128/MCB.16.11.6029 Li, 1997, Receptor-associated coactivator 3, a steroid/nuclear receptor coactivator that is related to steroid receptor coactivator 1 and transcriptional intermediate factor 2., Proc. Natl. Acad. Sci. U.S.A., 94, 8479, 10.1073/pnas.94.16.8479 Liao, 1990, Vitamin D receptor interaction with specific DNA requires a nuclear protein and 1,25-dihydroxyvitamin D3, Proc. Natl. Acad. Sci. U.S.A., 87, 9751, 10.1073/pnas.87.24.9751 Love, 1992, Effects of tamoxifen on bone mineral density in post menopausal women with breast cancer., N. Engl. J. Med., 326, 852, 10.1056/NEJM199203263261302 Lu, 1993, DNA bending by retinoid X receptor-containing retinoid and thyroid hormone receptor complexes., Mol. Cell. Biol., 13, 6509, 10.1128/MCB.13.10.6509 Luisi, 1991, Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA., Nature (London, 352, 497, 10.1038/352497a0 Lundblad, 1995, Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP., Nature (London, 374, 85, 10.1038/374085a0 Mangelsdorf, 1995, The RXR Heterodimers and Orphan receptors., Cell (Cambridge, Mass., 83, 841, 10.1016/0092-8674(95)90200-7 Mangelsdorf, 1990, Nuclear receptor that identifies a novel retinoic acid response pathway., Nature (London, 345, 224, 10.1038/345224a0 Mangelsdorf, 1995, The nuclear receptor superfamily: The second decade., Cell (Cambridge, Mass., 83, 835, 10.1016/0092-8674(95)90199-X May, 1996, Human TAFII28 promotes transcriptional stimulation by activation function 2 of the retinoid X receptors., EMBO J., 15, 3093, 10.1002/j.1460-2075.1996.tb00672.x McDonnell, 1995, Analysis of estrogen receptor function in vitro reveals three distinct classes of anti-estrogens., Mol. Endocrinol., 9, 659, 10.1210/me.9.6.659 McInerney, 1996, Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator., Proc. Natl. Acad. Sci. U.S.A., 93, 10069, 10.1073/pnas.93.19.10069 Mengus, 1997, Human TAFII135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells., Genes Dev., 11, 1381, 10.1101/gad.11.11.1381 Metzger, 1995, Characterization of the amino terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells., J. Biol. Chem., 270, 9535, 10.1074/jbc.270.16.9535 Metzger, 1995, Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo., Mol. Endocrinol., 9, 579, 10.1210/me.9.5.579 Meyer, 1989, Steroid hormone receptors compete for factors that mediate their enhancer function., Cell (Cambridge, Mass., 57, 433, 10.1016/0092-8674(89)90918-5 Meyer, 1990, Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor., EMBO J., 9, 3923, 10.1002/j.1460-2075.1990.tb07613.x Michalak, 1996, Endoplasmic reticulum form of calreticulin modulates glucocorticoid-sensitive gene expression., J. Biol. Chem., 271, 29436, 10.1074/jbc.271.46.29436 Migliaccio, 1996, Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells., EMBO J., 15, 1292, 10.1002/j.1460-2075.1996.tb00471.x Mukherjee, 1990, A single-stranded DNA-binding protein promotes the binding of the purified oestrogen receptor to its responsive element., Nucleic Acids Res., 18, 5713, 10.1093/nar/18.19.5713 Murray, 1989, Identification of nuclear factors that enhance binding of the thyroid hormone receptor to a thyroid hormone response element., Mol. Endocrinol., 3, 1434, 10.1210/mend-3-9-1434 Nagpal, 1992, Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors., Cell (Cambridge, Mass., 70, 1007, 10.1016/0092-8674(92)90250-G Nagy, 1997, Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase., Cell (Cambridge, Mass., 89, 373, 10.1016/S0092-8674(00)80218-4 Nardulli, 1992, Binding of the estrogen receptor DNA-binding domain to the estrogen response element induces DNA bending., Mol. Cell Biol., 12, 2037, 10.1128/MCB.12.5.2037 Nardulli, 1995, Estrogen receptor induced DNA bending: Orientation or the bend and replacement of an estrogen response element with an intrinsic DNA binding sequence., Mol. Endocrinol., 9, 1064, 10.1210/me.9.8.1064 O'Donnell, 1990, Mutational analysis identifies a new functional domain at the thyroid hormone receptor., Mol. Endocrinol., 4, 715, 10.1210/mend-4-5-715 Ogryzko, 1996, The transcriptional coactivators p300 and CBP are histone acetyltransferases., Cell (Cambridge, Mass., 87, 953, 10.1016/S0092-8674(00)82001-2 Onate, 1991, Evidence that heat shock protein-70 associated with progesterone receptors is not involved in receptor-DNA binding., Mol. Endocrinol, 5, 2004, 10.1210/mend-5-12-1993 Onate, 1994, The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences., Mol. Cell. Biol., 14, 3376, 10.1128/MCB.14.5.3376 Onate, 1995, Sequence and characterization of a coactivator for the steroid hormone receptor superfamily., Science, 270, 1354, 10.1126/science.270.5240.1354 Onate, 1998, The steroid receptor coactivator-one (SRC-1) contains multiple receptor interacting and activation domains that cooperatively enhance the AF-1 and AF-2 domains of steroid receptors., J. Biol. Chem, 273, 12101, 10.1074/jbc.273.20.12101 Orti, 1993, Kinetics of glucocorticoid receptor phosphorylation in intact cells., J. Biol. Chem., 268, 7779, 10.1016/S0021-9258(18)53026-X Parker, 1995, Structure and function of estrogen receptors., Vitam. Horm. (N.Y., 51, 267, 10.1016/S0083-6729(08)61041-9 Paull, 1996, Yeast HMG proteins NHP6A/B potentiate promoter-specific transcriptional activation in vivo and assembly of preinitiation complexes, in vitro. Genes Dev., 10, 2769, 10.1101/gad.10.21.2769 Pazin, 1997, What's up and down with histone deacetylation and transcription?, Cell (Cambridge, Mass., 69, 325, 10.1016/S0092-8674(00)80211-1 Pham, 1992, Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast., Mol. Endocrinol., 6, 1043, 10.1210/me.6.7.1043 Pil, 1993, High-mobility-group 1 protein mediates DNA bending as determined by ring closures., Proc. Natl. Acad. Sci. U.S.A., 90, 9465, 10.1073/pnas.90.20.9465 Pratt, 1997, Steroid receptor interactions with heat shock protein and immunophilin chaperones., Endocr. Rev., 18, 306, 10.1210/er.18.3.306 Prendergast, 1994, Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA., J. Steroid Biochem. Mol. Biol., 48, 1, 10.1016/0960-0760(94)90245-3 Prendergast, 1996, Progesterone receptor-induced bending of its target DNA: Distinct effects of the A and B receptor forms., Mol. Endocrinol., 10, 393, 10.1210/me.10.4.393 Rastinejad, 1995, Structural determinants of nuclear receptor assembly on DNA direct repeats., Nature (London, 375, 203, 10.1038/375203a0 Read, 1993, Solution structure of a DNA-binding domain from HMG1., Nucleic Acids Res., 21, 3427, 10.1093/nar/21.15.3427 Read, 1995, The structure of the HMG box and its interaction with DNA., Nucleic Acids Mol. Biol., 9, 221 Reese, 1991, Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: Studies using human estrogen receptor overexpressed in mammalian cell., Nucleic Acids Res., 19, 6595, 10.1093/nar/19.23.6595 Reese, 1992, Examination of the DNA-binding ability of estrogen receptor in whole cells/implications for hormone-independent transactivation and the actions of antiestrogens., Mol. Cell. Biol., 12, 4531, 10.1128/MCB.12.10.4531 Renaud, 1995, Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid., Nature (London, 378, 681, 10.1038/378681a0 Rochette-Egly, 1992, Retinoic acid receptor-β: Immunodetection and phosphorylation on tyrosine residues., Mol. Endocrinol., 66, 2197, 10.1210/me.6.12.2197 Roderick, 1997, Nuclear localization of calreticulin in vivo is enhanced by its interaction with glucocorticoid receptors., FEBS Lett., 405, 181, 10.1016/S0014-5793(97)00183-X Ross, 1992, A nuclear protein essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its response elements., Proc. Natl. Acad. Sci. U.S.A., 89, 256, 10.1073/pnas.89.1.256 Rubin, 1996, Identification of the ga14 suppressor Sug1 as a subunit of the yeast 26S proteasome., Nature (London, 379, 655, 10.1038/379655a0 Santen, 1996, Editorial: Long term tamoxifen therapy: Can an antagonist become an agonist?, J. Clin. Endocrinol. Metab., 81, 2027, 10.1210/jc.81.6.2027 Schwabe, 1990, Solution structure of the DNA-binding domain of the oestrogen receptor., Nature (London, 348, 458, 10.1038/348458a0 Schwabe, 1993, The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements., Cell (Cambridge, Mass., 75, 567, 10.1016/0092-8674(93)90390-C Schwerk, 1995, Identification of a transactivation function in the progesterone receptor that interacts with the TAFII110 subunit of the TFIID complex., J. Biol. Chem., 270, 21331, 10.1074/jbc.270.36.21331 Shago, 1997, Modulation of the retinoic acid and retinoid X receptor signaling pathways in P19 embryonal carcinoma cella by calreticulin., Exp. Cell Res., 230, 50, 10.1006/excr.1996.3408 Shykind, 1995, Activation of the TFIID-TFIIA complex with HMG-2., Genes Dev., 9, 1354, 10.1101/gad.9.11.1354 Simons, 1998, Structure and function of the steroid and nuclear receptor ligand-binding domain., 35 Smith, 1996, CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription., Proc. Natl. Acad. Sci. U.S.A., 93, 8884, 10.1073/pnas.93.17.8884 Smith, 1997, Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen., Mol. Endocrinol., 11, 657, 10.1210/me.11.6.657 Sone, 1991, A 55-kilodalton accessory factor facilitates vitamin D receptor DNA binding., Mol. Endocrinol., 5, 1578, 10.1210/mend-5-11-1578 Spencer, 1997, Steroid receptor coactivator-1 is a histone acetyltransferase., Nature (London, 389, 194, 10.1038/38304 Srinivasan, 1994, Heat shock protein is tightly associated with the recombinant human glucocorticoid receptor: Glucocorticoid response element complex., Mol. Endocrinol., 8, 189, 10.1210/me.8.2.189 Arnaud, 1995, Constitutive expression of calreticulin in osteoblasts inhibits mineralization., J. Cell Biol., 131, 1351, 10.1083/jcb.131.5.1351 Takeshita, 1996, Molecular cloning properties of a full-length putative thyroid hormone receptor coactivator., Endocrinology (Baltimore, 137, 3594, 10.1210/en.137.8.3594 Takimoto, 1992, Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: Analysis with zinc-finger mutants and the progesterone antagonist ZK98299., Proc. Natl. Acad. Sci. U.S.A., 89, 3050, 10.1073/pnas.89.7.3050 Takimoto, 1996, Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors., J. Biol. Chem., 271, 13308, 10.1074/jbc.271.23.13308 Tasset, 1990, Distinct classes of transcriptional activating domains function by different mechanisms., Cell (Cambridge, Mass., 62, 1177, 10.1016/0092-8674(90)90394-T Tora, 1989, The human estrogen receptor has two independent nonacidic transcriptional activation functions., Cell (Cambridge, Mass., 59, 477, 10.1016/0092-8674(89)90031-7 Torchia, 1997, The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function., Nature (London, 387, 677, 10.1038/42652 Tremethick, 1988, Effects of high mobility group proteins 1 and 2 on initiation and elongation of specific transcription by RNA polymerase II, in vitro. Nucleic Acids Res., 16, 11107, 10.1093/nar/16.23.11107 Truss, 1993, Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors., Endocrin Rev., 14, 459 Tsai, 1994, Molecular mechanisms of action of steroid/thyroid receptor superfamily members., Annu. Rev. Biochem., 63, 451, 10.1146/annurev.bi.63.070194.002315 Tymoczko, 1988, Identification of a protein from rat liver cytosol that enhances activation of the glucocorticoid receptor., Biochem. J., 256, 47, 10.1042/bj2560047 Tzukerman, 1994, Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions., Mol. Endocrinol., 8, 21, 10.1210/me.8.1.21 Vegeto, 1992, The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor., Cell (Cambridge, Mass., 69, 703, 10.1016/0092-8674(92)90234-4 Verrier, 1997, High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAFII30 affect estrogen receptor-mediated transcriptional activation., Mol. Endocrinol., 11, 1009, 10.1210/me.11.8.1009 Voegel, 1996, TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors., EMBO J., 15, 3667, 10.1002/j.1460-2075.1996.tb00736.x Wagner, 1996, 16α-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity., Proc. Natl. Acad. Sci. U.S.A., 93, 8739, 10.1073/pnas.93.16.8739 Wagner, 1998, The nuclear corepressors NcoR and SMART are key regulators of both ligand and 8-bromo-cAMP dependent transcriptional activity of the human progesterone receptor., Mol. Cell. Biol., 18, 1369, 10.1128/MCB.18.3.1369 Wagner, 1995, A structural role for hormone in the thyroid hormone receptor., Nature (London, 378, 690, 10.1038/378690a0 Walfish, 1997, Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors., Proc. Natl. Acad. Sci. U.S.A., 94, 3697, 10.1073/pnas.94.8.3697 Webster, 1997, Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein., J. Biol. Chem., 272, 9287, 10.1074/jbc.272.14.9287 Weigel, 1996, Steroid hormone receptors and their regulation by phosphorylation., Biochem. J., 319, 657, 10.1042/bj3190657 Weigel, 1992, Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody., Mol. Endocrinol., 6, 1585, 10.1210/me.6.10.1585 Weir, 1993, Structure of the HMG box motif in the B-domain of HMG1., EMBO J., 12, 1311, 10.1002/j.1460-2075.1993.tb05776.x Wheeler, 1995, Calreticulin inhibits vitamin D3 signal transduction., Nucleic Acids Res., 23, 3268, 10.1093/nar/23.16.3268 Winrow, 1995, Calreticulin modulates in vitro DNA binding but not the in vivo transcriptional activation by peroxisome proliferator-activated receptor/retinoid X receptor heterodimers., Mol. Cell. Endocrinol., 111, 175, 10.1016/0303-7207(95)03563-M Winston, 1992, Analysis of SPT genes: A genetic approach toward analysis of TFIID, histones, and other transcription factors of yeast., 1271 Wolffe, 1994, Architectural transcription factors., Science, 264, 1100, 10.1126/science.8178167 Wolffe, 1996, Targeting chromatin disruption: Transcription regulators that acetylate histones., Cell (Cambridge, Mass., 84, 817, 10.1016/S0092-8674(00)81059-4 Wurtz, 1996, A canonical structure for the ligand-binding domain of nuclear receptors., Nat. Struct. Biol., 3, 87, 10.1038/nsb0196-87 Yang, 1996, Assessment of glucocorticoid receptor-heat shock protein 90 interactions in vivo during nucleocytoplasmic trafficking., Mol. Endocrinol., 10, 3, 10.1210/me.10.1.3 Yang, 1996, A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A., Nature (London, 382, 319, 10.1038/382319a0 Yao, 1992, Drosophila ultraspiracle modulates ecdysome receptor function via heterodimer formation., Cell (Cambridge, Mass., 71, 63, 10.1016/0092-8674(92)90266-F Yao, 1996, The nuclear hormone receptor coactivator SRC-1 is a specific target of p300., Proc. Natl. Acad. Sci. U.S.A., 93, 10626, 10.1073/pnas.93.20.10626 Yeh, 1996, Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells., Proc. Natl. Acad. Sci. U.S.A., 93, 5518, 10.1073/pnas.93.11.5517 Yu, 1995, Differential activation of peroxisome proliferator-activated receptors by eicosanoids., J. Biol. Chem., 270, 23975, 10.1074/jbc.270.41.23975 Yu, 1991, RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements., Cell (Cambridge, Mass., 67, 1251, 10.1016/0092-8674(91)90301-E Zappavigna, 1996, HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation., EMBO J., 15, 4981, 10.1002/j.1460-2075.1996.tb00878.x Zhang, 1992, Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors., Nature (London, 355, 441, 10.1038/355441a0 Zhang, 1995, Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor., Mol. Endocrinol., 9, 1029, 10.1210/me.9.8.1029 Zilliacus, 1995, Structural determinants of DNA-binding specificity by steroid receptors., Mol. Endocrinol., 9, 389, 10.1210/me.9.4.389 Zwilling, 1995, High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors., EMBO J., 14, 1198, 10.1002/j.1460-2075.1995.tb07103.x